Evonik Invests CAD 150 Million in New GMP Lipid-Based Drug Manufacturing Facility in Vancouver

Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evoni...

August 31, 2026 | Monday | News
Teva Bids to Acquire BioXcel’s Novel At-Home Neuroscience Treatment for Agitation

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. announced it has made a bid to acquire an innovative neurosc...

August 31, 2026 | Monday | News
Lexicon Earns Third $10 Million Milestone Payment From Novo Nordisk for LX9851

Lexicon Pharmaceuticals, Inc.  announced that it has earned a third $10 million milestone payment in 2026 from Novo Nordisk A/S following the achiev...

August 26, 2026 | Wednesday | News
Quotient Sciences on How AI Is Reshaping the CDMO–Sponsor Relationship

    As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors im...

August 25, 2026 | Tuesday | Interaction
Milestone Pharmaceuticals Enrolls First Patient in Phase 3 Trial of Etripamil for AFib-RVR

Milestone® Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medi...

August 24, 2026 | Monday | News
Alvotech and Lotus Pharmaceutical Partner to Commercialize Two Biosimilar Candidates in U.S. and Asia

Alvotech , a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced a str...

August 24, 2026 | Monday | News
SK pharmteco Opens Expanded Manufacturing Facilities at Swords Campus in Ireland

SK pharmteco recently hosted a formal ribbon-cutting ceremony to mark the official opening of two major facility expansions at its manufacturing campus i...

August 20, 2026 | Thursday | News
Immunocine Cancer Center Opens Second Treatment Location in Cabo San Lucas

Responding to a growing number of patients seeking personalized cancer immunotherapy, Immunocine Cancer Center has opened a second treatment location in ...

August 20, 2026 | Thursday | News
Aurisco Pharmaceutical Passes USFDA Inspection as First Generic Oligonucleotide API Manufacturer

Aurisco Pharmaceutical, a leading global Oligonucleotide and Peptide (TIDES) manufacturer, announced that its site in Yangzhou, China has passed the USFDA ...

August 17, 2026 | Monday | News
Cycle Pharmaceuticals Partners With Forma to Manufacture CAVHANZA in U.S.

Cycle Pharmaceuticals (“Cycle”), a global pharmaceutical company focused on rare diseases, and Forma Life Sciences, Inc. (“Forma”...

August 14, 2026 | Friday | News
NurExone Signs MOU With Made Scientific for U.S. GMP Exosome Manufacturing Partnership

NurExone Biologic Inc. ("NurExone" or the "Company") (TSXV: NRX, OTCQB: NRXBF, FSE: J90), a biotechnology company developing exosome-based regenerative t...

August 14, 2026 | Friday | News
Fresenius Kabi Recalls Tyenne Injection Lot Over Glass Particle Contamination

Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 m...

August 12, 2026 | Wednesday | News
CellFiber and Tidewave Bio Collaborate to Advance Manufacturing of Off-the-Shelf Cell Therapy

CellFiber Co., Ltd. (“CellFiber”), a Tokyo-based biotechnology company built on its proprietary CellFiber® cell encapsulation platform, a...

August 07, 2026 | Friday | News
Building Confidence Beyond Compliance With Media Fills Designed for the Annex 1 Era

In the Annex 1 era, media fills must replicate the routine aseptic manufacturing process as closely as possible. This includes all critical manufacturing s...

August 03, 2026 | Monday | Expert Opinion

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close